Moreover, the pathway enrichment analysis results suggested that approximately 80% of uPAR-mediated signaling crosstalked to the identified 10 cancer pathways, where the MAPK and PI3K-AKT pathways were evident to be the most augmented. The gene discussed is PLAUR; the disease is cancer.